FDA agrees to fast-track review of Amarin’s prescription strength fish oil pill for heart patients

The FDA plans to review Vascep within six months instead of the usual 10, with a decision on approval expected sometime in late September. Health and Science U.S.HEALTHCARE UPDATE: Click today to request your free ACRX discount prescription card and … Read more…